|
Volumn 18, Issue 13 Suppl 7, 2004, Pages 5-14
|
Management of invasive mycoses in hematology patients: current approaches.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMPHOTERICIN B;
AMPHOTERICIN B DEOXYCHOLATE;
AMPHOTERICIN B-DEOXYCHOLATE;
ANTIFUNGAL AGENT;
CYCLOPEPTIDE;
DEOXYCHOLIC ACID;
ECHINOCANDIN B;
FUNGAL PROTEIN;
LIPOSOME;
TRIAZOLE DERIVATIVE;
ANTIBIOTIC RESISTANCE;
ASPERGILLOSIS;
CANDIDIASIS;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DOSE RESPONSE;
DRUG ADMINISTRATION;
DRUG COMBINATION;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMAN;
MYCOSIS;
NEOPLASM;
NEUTROPENIA;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
SURVIVAL;
AMPHOTERICIN B;
ANTIBIOTICS, ANTIFUNGAL;
ANTIFUNGAL AGENTS;
ASPERGILLOSIS;
CANDIDIASIS;
DEOXYCHOLIC ACID;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
DRUG COMBINATIONS;
DRUG RESISTANCE, FUNGAL;
FUNGAL PROTEINS;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
LIPOSOMES;
MYCOSES;
NEOPLASMS;
NEUTROPENIA;
PEPTIDES, CYCLIC;
RANDOMIZED CONTROLLED TRIALS;
SURVIVAL ANALYSIS;
TRIAZOLES;
|
EID: 13944260541
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (17)
|
References (41)
|